
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis”, Neurology, vol. 79, pp. 922-8, 2012.
, “Risk of fracture with thiazolidinediones: an individual patient data meta-analysis”, Front Endocrinol (Lausanne), vol. 4, p. 11, 2013.
, “Allopurinol initiation and change in blood pressure in older adults with hypertension”, Hypertension, vol. 64, pp. 1102-7, 2014.
, “Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence”, BMJ Open, vol. 6, p. e010508, 2016.
, “Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors”, Eye (Lond), vol. 32, pp. 1028-1035, 2018.
, “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
, “Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis”, Int J Cancer, vol. 137, pp. 2424-31, 2015.
, “Metformin and the risk of head and neck cancer: a case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
, “Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis”, Ophthalmology, vol. 124, pp. 1635-1639, 2017.
, “Metformin and the risk of renal cell carcinoma: a case-control analysis”, Eur J Cancer Prev, vol. 26, pp. 257-262, 2017.
, “ACE inhibitor use and risk of cataract: a case-control analysis”, Br J Ophthalmol, 2019.
, “Cancer risk in association with Parkinson disease: a population-based study”, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
, “Risk of stroke in patients with idiopathic Parkinson disease”, Parkinsonism Relat Disord, vol. 16, pp. 31-5, 2010.
, “Risk of incident depression in patients with Parkinson disease in the UK”, Eur J Neurol, vol. 18, pp. 448-53, 2011.
, “NSAID use and risk of Parkinson disease: a population-based case-control study”, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
, “Metformin and the risk of endometrial cancer: a case-control analysis”, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Migraine and the risk of stroke, TIA, or death in the UK (CME)”, Headache, vol. 47, pp. 1374-84, 2007.
, “Migraine incidence, comorbidity and health resource utilization in the UK”, Cephalalgia, vol. 28, pp. 57-64, 2008.
, “The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions”, Headache, vol. 48, pp. 606-10, 2008.
, “Diabetes in patients with idiopathic Parkinson's disease”, Diabetes Care, vol. 31, pp. 1808-12, 2008.
, “Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK”, Drug Saf, vol. 31, pp. 399-407, 2008.
, “Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study”, Pain, vol. 157, pp. 1525-31, 2016.
, “Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink”, Eur J Pain, 2019.
, “Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations”, Sci Rep, vol. 5, p. 15246, 2015.
, “Exploring Severe Mental Illness and Diabetes: Protocol for a Longitudinal, Observational, and Qualitative Mixed Methods Study”, JMIR Res Protoc, vol. 8, p. 13407, 2019.
, “Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom”, Adv Ther, vol. 28, pp. 1096-104, 2011.
, “Type 2 diabetes and the risk of mortality among patients with prostate cancer”, Cancer Causes Control, vol. 25, pp. 329-38, 2014.
, “Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study”, BMC Neurol, vol. 12, p. 8, 2012.
, “Lower respiratory tract infection in the first year of life is associated with worse lung function in adult life: prospective results from the Barry Caerphilly Growth study”, Ann Epidemiol, vol. 23, pp. 422-7, 2013.
, “The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)”, PLoS One, vol. 14, p. e0223253, 2019.
, “Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes”, J Clin Endocrinol Metab, vol. 103, pp. 2116-2125, 2018.
, “Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012”, Curr Med Res Opin, vol. 32, pp. 1023-32, 2016.
, “Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study”, Antibiotics (Basel), vol. 5, 2016.
, “Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study”, BMJ Open, vol. 7, p. e013398, 2017.
, “Combined oral contraceptive use and the risk of systemic lupus erythematosus”, Arthritis Rheum, vol. 61, pp. 476-81, 2009.
, “Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study”, Age Ageing, 2020.
, “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults”, Lancet, vol. 384, pp. 755-65, 2014.
, “Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database”, Bmj, vol. 344, p. e2697, 2012.
, “Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 3, p. e003389, 2013.
, “Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK”, Lancet Diabetes Endocrinol, vol. 6, pp. 944-953, 2018.
, “Coding, recording and incidence of different forms of coronary heart disease in primary care”, PLoS One, vol. 7, p. e29776, 2012.
, “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.
, “Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care”, BMC Med, vol. 18, p. 195, 2020.
, “Iron supplementation in Switzerland - A bi-national, descriptive and observational study”, Swiss Med Wkly, vol. 147, p. w14444, 2017.
, “Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records”, Cancer Med, vol. 6, pp. 2453-2460, 2017.
, “Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study”, Arthritis Res Ther, vol. 17, p. 375, 2015.
, “Etiology and frequency of rhabdomyolysis”, Pharmacotherapy, vol. 22, pp. 1524-6, 2002.
, “Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill”, Br J Clin Pharmacol, vol. 53, pp. 637-40, 2002.
, ,